Sanomedics International Holdings focuses on providing products, services and ideas through collaborative efforts between physicians, entrepreneurs, and medical companies. Together these groups bridge the gap between the high-technology medical world and the home healthcare environment. The net result is one that drives innovative technologies from concept to development, and ultimately revenue producing market sales. Sanomedics plans to grow its business through acquisitions, operating within the sleep disorder diagnosis treatments space. SIMH is active in its pursuit to acquire sleep therapy operating businesses. Its strategy involves integrating a portfolio of world-class products and service providers in the growing sleep apnea market. Its goal is to provide sleep apnea patients with a reliable “end-to-end” solution.
The market opportunity appears to be bright as sleep apnea is estimated to affect about 4% of men and 2% of women. In one study referenced at MedicineNet.com of people over 18 years of age, “obstructive sleep apnea was estimated to develop in 1.5% of people per year over the 5 year study. It is probably more common than either of these numbers because the population is becoming more obese, and obesity worsens obstructive sleep apnea.”
Within the highly competitive, preventative medicine marketplace, investors can rest assured Sanomedics is engaged in activity necessary for its financial health and viability. The company has just announced its liabilities have been reduced by 8% and in so doing has strengthened its balance sheet following the restructure of $1 Million, plus interest, in debt owed to TCA Global Credit Master Fund LP (“TCA”). The restructure of its TCA debt was announced in a press release and a Form 8-K filed with the Securities and Exchange Commission on September 29, 2014.
Sanomedics President, Keith Houlihan, added, “Our plans to build a solid foundation and strengthen the value of this company and its balance sheet, while garnering financial flexibility have not wavered in the slightest. Rather, they have been re-energized with this modest, but significant improvement in our liabilities. We remain committed to putting this company on the right path to long term growth and appreciation for benefit of not only Sanomedics and our shareholders, but also those in the healthcare industry that need innovative solutions to meet the patient care and safety demands that come with our growing and aging population.”
Additionally, SIMH designs, develops, markets, and distributes a line of non-contact clinical thermometers in the United States. The company’s products are served to the market under the Caregiver name to healthcare providers. This group includes hospitals, medical clinics, physician’s offices, assisted living facilities, acute care hospitals, and a variety of long-term care institutions. It sells its products through distributors, resellers, and sales representatives and is located in Miami, Florida.
For more information on the company, visit www.sanomedics.com
Let us hear your thoughts below:
